Recombinant fibrinogen-like protein 2 improved DSS-induced colitis by reversing the decline in gut microbiota diversity and restoring BA homeostasis by decreasing total BA, increasing FXR and FGF15, and downregulating CYP7A1 [223]. The gene discussed is CYP7A1; the disease is colitis.